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Approximately 645 people suffer from blunt force trauma injury to the femur every day. The recovery 
time of such injury can last anywhere from 3-6 months. Thrombopoietin (TPO) was used as a growth 
factor to induce bone and muscle healing. In this study, nine separate mouse groups (10 mice per group) 
were used:  Crush PBS, Crush TPO, Surgery PBS, and Surgery TPO at day 3 and day 17, and controls 
with no surgery/crush/treatment. Skeletal muscle was harvested from the following sites: experimental 
impact, experimental adjacent, and normal contralateral skeletal muscle as a control. The muscles were 
fixed, processed, sectioned, and stained with H&E and Massons Trichrome stains. The slides were 
reviewed for skeletal muscle injury, muscle necrosis, inflammation, muscle repair, and regeneration. In 
addition, F4/80, an immunostain for macrophages was performed. On microscopic examination at day 3 
the most common histologic changes seen were sporadic muscle fiber vacuolation, focal necrosis of 
varying sizes, muscle contraction bands, and infiltration of macrophages. On day 17, the skeletal muscle 
injury was generally healed. The main histologic lesions seen were variable sizes of muscle fibers, early 
fibroplasia, fat infiltration, some macrophages, satellite cells, and neovascularization. Comparing the TPO 
treated mice versus the PBS control group, the lesions at both time points were less in the TPO treated 
mice.  
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